$15.27
00.00%
Pre-Market: 4:01 PM EDT
15 minutes delayed
Comments
Loading...
Gyre Therapeutics
GYRENASDAQ
Gyre Therapeutics (NASDAQ:GYRE) Stock, Earnings Estimates, EPS, And Revenue
Gyre Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 9
EPS
$0.030
Quarterly Revenue
$27.2M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$115.7M
Analyze the earnings history of Gyre Therapeutics using advanced sorting and filters.
Gyre Therapeutics (GYRE) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Gyre Therapeutics (GYRE) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Gyre Therapeutics (NASDAQ:GYRE) reporting earnings?
Gyre Therapeutics (GYRE) is scheduled to report earnings on August 21, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
What were the latest earnings per share (EPS) for Gyre Therapeutics (NASDAQ:GYRE)?
The Actual EPS was $0.03, which beat the estimate of $0.00.
What were Gyre Therapeutics’s (NASDAQ:GYRE) revenues?
The Actual Revenue was $27.2M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.